Dr. Mahal is an internationally recognized expert in prostate cancer and health equity, with over 200 co-authored manuscripts including several publications in top medical journals such as NEJM, JAMA, and JAMA Oncology. Dr. Mahal has served on several expert committees and panels, including The White House’s Health Equity Leader Roundtable, The Lancet Commission on Prostate Cancer, The American Society for Clinical Oncology(ASCO) Guideline Panel on Genomics for Prostate Cancer, ASCO-Friends Cancer Research Group, American Cancer Society (ACS) National Advisory Team on Prostate Cancer Disparities, and Prostate Cancer Foundation Disparities Working Group.